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Abstract  
A Therapeutic Nipple Shield (TNS) was previously developed to respond to the global need for 
new infant drug delivery technologies. However, the release efficiency for the same Active 
Pharmaceutical Ingredient (API) from different therapeutic matrices within the TNS 
formulation has not yet been investigated. To address this, in-vitro release of elemental zinc 
into human milk from two types of Texel non-woven fibre mats of varying thickness and 
different gram per square meter values, placed inside the TNS was explored and compared to 
the release from zinc-containing rapidly disintegrating tablets. In-vitro delivery was performed 
by means of a breastfeeding simulation apparatus, with human milk flow rates and suction 
pressure adjusted to physiologically relevant values, and release was quantified using 
Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). It was found that a 
total recovery of 62 - 64 % elemental zinc was obtained after the human milk had passed 
through the fibre insert, amounting to a 20 - 48% increase compared to previous zinc delivery 
studies using rapidly disintegrating tablets within the TNS. This indicates that non-woven Texel 
fibre mats were identified as the superior dosage form for zinc oral drug delivery into human 
milk using a TNS.  
Keywords: pediatrics; oral delivery; breastfeeding; human milk; medication systems; X-ray 
Micro Computed Tomography 
 
  
Page 3 of 24 
 
Graphical Abstract 
 
 
  
Page 4 of 24 
 
1. Introduction  
New infant drug delivery technologies are urgently needed. According to the World Health 
Organization (WHO), many of the 5.9 million child deaths worldwide before the age of five 
could be prevented by enabling access to affordable interventions, capable of addressing the 
current challenges of low-resource settings, such as lack of potable water or sterilisation 
(IGME, 2015; World Health Organization, 2007). This clearly indicates that novel, affordable 
and easy-to-use infant drug delivery technologies are urgently needed. To address current 
limitations, a Therapeutic Nipple Shield (TNS) was developed (Gerrard et al., 2012), which 
enables the delivery of Active Pharmaceutical Ingredients (APIs) during breastfeeding. It 
consists of a nipple shield device containing a therapeutic insert, for example in the form of an 
API-loaded tablet or fibrous material. When worn by a mother during breastfeeding, such a 
device enriches the human milk consumed by the suckling infant with medication or nutrients 
(see Figure 1) (Gerrard et al., 2012). 
 
  
Figure 1: Working principle of the T167KH716 LVSODFHGRQ WKHPRWKHU¶VEUHDVWGXULQJ
breastfeeding, while the flow of human milk delivers the therapeutic to the suckling infant. (a) 
Nipple shield device, (b) Active Pharmaceutical Ingredient (API). 
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The TNS has the potential to dramatically change the way drugs are administered to infants 
worldwide, as it could potentially improve the acceptability of pharmaceutical products in both 
developed and developing countries (Lopez and Ernest, 2015), and offer an alternative to 
conventional drug delivery for the 36 % of infants aged 0 - 6 months, who are exclusively 
breastfed (World Health Organization, 2017).  
Zinc is a physiologically important element, responsible for the activity of various proteins in 
major pathways of the human metabolism (Terrin et al., 2015). Its deficiency has extensive 
effects on growth and development of infants, as well as the capabilities of the body's immune 
system (Caulfield et al., 1998; Terrin et al., 2015; Wulf et al., 2013). The intestinal absorption 
of zinc is independent of zinc status, yet higher uptake is reported for term babies as a result of 
lower zinc concentration in the blood serum (Terrin et al., 2015). Preterm and Small for 
Gestational Age (SGA) neonates have an increased risk of zinc deficiency (Wulf et al., 2013), 
which is believed to occur within the first 1 - 2 months of life (Caulfield et al., 1998). 
Breastfeeding infants obtain zinc through the consumption of human milk, however, zinc 
concentration can exhibit significant variations (0.7 - 1.6 mg l-1), and constantly declines 
postpartum:  
8 - 12 mg l-1 zinc can be found in colostrum, the first milk the maternal breast produces after 
giving birth, 3 - 6 mg l-1 in human  milk seven days after birth, and only 1- 3 mg l-1 an additional 
three weeks later (Terrin et al., 2015). To prevent deficiency, enteral delivery of zinc is 
recommended, being 0.8 mg kg-1 day-1 for term infants and 3 mg kg-1 day-1 for preterm neonates 
(Hambidge and Krebs, 2004). If zinc deficiency occurs, it is associated with conditions such as 
dermatitis, growth retardation, necrotizing enterocolitis, neurologic damage, 
bronchopulmonary dysplasia, infections, and retinopathy of prematurity (Terrin et al., 2015). It 
is recognized that not only severe, but also moderate zinc deficiency is adding to ³WKH WRWDO
EXUGHQRIGLVHDVH´in infants leading to about 800,000 child deaths every year (Black, 2003). 
,Q DGGLWLRQ WR ]LQF¶V JHQHUDO KHDOWK SURPRWLQJ HIIHFWV WKH WHO recommends use of zinc  
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(20 mg zinc sulphate) as an adjunct supplement to oral rehydration salts for the treatment of 
acute diarrhoea (World Health Organization, 2015). Due to the significance of zinc for the 
physical development and wellbeing of infants globally, its delivery into human milk using the 
TNS was investigated in this study. 
To aid in-vitro testing of the TNS, a breastfeeding simulation apparatus was developed by 
Gerrard et al., simulating both the process of lactation and infant feeding by mimicking the 
average flow rates/patterns of milk during breastfeeding and the LQIDQW¶V suckling pressure 
(Gerrard et al., 2013). The apparatus was previously used to investigate release of a 
Sulforhodamine B dye and of zinc sulphate from rapidly disintegrating tablets into human milk 
(Gerrard et al., 2012; Scheuerle et al., 2017). The capability of non-woven fibres to release APIs 
into human milk was previously shown by Gerrard et al., who investigated the delivery of 
Sodium Dodecyl Sulphate (SDS) from loaded non-woven fibres (Bathfelt, Texel, Qubec, 
Canada) located within a Sinnex filter holder, but without the use of breastfeeding simulation 
(Gerrard et al., 2012). The following research builds on both studies and explored the fibre-
based zinc sulphate delivery from a nipple shield device into human milk using the 
breastfeeding simulation apparatus. It is the first time that absolute recovery of the same 
compound using different dosage forms within the TNS has been quantitatively compared. 
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2. Materials and methods  
2.1. Materials 
In accordance with previous fibre studies by Gerrard et al. (Gerrard et al., 2012), non-woven 
fibre mats (35% viscose, 65% polyester), provided from Bathfelt, Texel (Qubec, Canada) were 
used as a delivery matrix. Two different types of fibre mats, placed within the same lip-
containing nipple shield device as previously applied for the evaluation of zinc delivery via 
rapidly disintegrating tablets by Scheuerle et al. (Scheuerle et al., 2017), were investigated: a 
235 gram per square meter (g m-2) felt with targeted thickness of 1.8 mm (referred to as fibre 
mat type A), and a 335 g m-2 felt with targeted thickness of 2.1 mm (referred to as fibre mat 
type B). An illustration can be found in Figure 2. Zinc sulphate monohydrate was obtained from 
Sigma Aldrich (Dorset, UK), and preferred over elemental zinc based on its superior solubility 
and taste characteristics (Scheuerle et al., 2017). Human milk samples were supplied by the 
4XHHQ&KDUORWWH¶VDQG&KHOVHD+RVSLWDO0LON%DQN,PSHULDO&ROOHJH+HDOWKFDUH1+67UXVW
and characterized as outlined in previous literature (Scheuerle et al., 2017), except that the fat 
content was calculated using an updated creamatocrit to fat correlation, published by Mitoulas 
et al. (Mitoulas et al., 2002). Human milk used for experiments in this study had a protein 
content of 43.52 g l-1, and a fat content of 16.51 g l-1. Both values correspond to previously 
reported literature data (Emmett and Rogers, 1997; Kent et al., 2006; Saarela et al., 2005). The 
Cambridge Human Biology Research Ethics Committee at the University of Cambridge 
approved all human milk sample use.  
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Figure 2: Fibres and nipple shield device used in the study. a - b) Illustration of non-woven 
fibre mat (a) type A and (b) type B, loaded with zinc sulphate. c - d) Lip-containing nipple 
shield device used for all breastfeeding simulation experiments.  
 
2.2. Methods 
2.2.1. Loading procedure 
6.2 mg (standard deviation 0.075 mg, n = 3) and 6.4 mg (standard deviation 0.046 mg, n = 3) 
of elemental zinc was loaded through administration of a 49 % zinc sulphate monohydrate 
solution (wt/wt %) onto type A and B fibre mats, respectively. Values were based on the WHO 
dose recommendation of zinc sulphate as an adjunct to oral rehydration salts for the treatment 
of acute diarrhoea (World Health Organization, 2015). All fibre mats were air dried in a petri 
dish for 24 hours at room temperature. 
 
2.2.2. Scanning Electron Microscope analysis  
Fibre mat cut-outs (diameter 10 mm), unloaded as well as loaded with zinc sulphate 
monohydrate respectively, were mounted on 12.5 mm Cambridge stubs with Silver Dag (Taab 
Ltd), sputter coated with 15 nm of iridium with a Quorum/Emitech K575X sputter coater, and 
viewed using a FEI Verios 460L Scanning Electron Microscope at 3 kV and 25 pA using a 
through lens detector operated in field free mode. 
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2.2.3. X-ray Micro Computed Tomography  
X-ray Micro Computed Tomography (XµCT) of the entire fibre mat was performed using a 
SkyScan 1172 high-resolution XµCT scanner (Bruker, Antwerp, Belgium), combining a cone 
beam geometry and a 2D array detector. By rotation of the object over 180¡ in steps of 0.25¡, 
shadow projections are acquired, from which a 3D image can be obtained following 
tomographic reconstruction. This imaging method was chosen due to its high spatial resolution  
and negligible diffraction in the investigated samples. Imaging was performed at an isotropic 
voxel size of 2.49 µm, 10 images per position were averaged to reduce noise and increase the 
contrast. The total acquisition time per sample amounted to approximately 3 h, in which 720 
images were recorded. Data obtained was reconstructed using NRecon (Bruker, v1.6.8.0), 
visualized in CTVox (Bruker, v3.3), and processed in Avizo Fire (FEI Company, Hillsboro, 
Oregon, USA, v8.1). Thresholding was applied to separate the solid material from the pore 
space for a subvolume (0.998 mm3) of the loaded and unloaded fibre mat. The volume and 
surface were calculated for the extracted solid material and the porosity was quantified by 
relating the volume of the pore space to that of the solid material. 
 
2.2.4. Delivery and quantification 
Calibration of the breastfeeding simulation DSSDUDWXV¶SXPSVSULRUWRDQ\H[SHULPHQWDOZRUN
being undertaken, as well as monitoring of temperature and pressure throughout the 
breastfeeding simulation was performed. Delivery of zinc was conducted in triplicate for each 
type of fibre mat by means of the breastfeeding simulation apparatus (Gerrard et al., 2013). 
Based on literature about breastfeeding physiology (Black et al., 1998; Geddes et al., 2008; 
Macias and Meneses, 2011; Moral et al., 2010), and in accordance with previous work 
conducted using the simulation apparatus (Gerrard and Larson, 2013; Scheuerle et al., 2017), a 
flow rate of approximately 5.0 mL min-1, a suction frequency of 1 suction/sec, and a temperature 
range of 33.4 - 33.7¡&VLPXODWLQJWKHOLNHO\WHPSHUDWXUHRIKXPDQPLONLQWKHLQIDQW¶VPRXWK 
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were chosen for all experiments. The pressure range and amplitude were adjusted to values of 
physiological relevance (Geddes et al., 2008). Peak vacuum values of -22.78 kPa and -22.32 
kPa as well as baseline vacuum values of -10.90 kPa and -11.38 kPa for fibre mat type A and 
B respectively were recorded. Figure 3 illustrates an exemplary average pressure profile for 
each type of fibre mat. All experiments were conducted in triplicate for each type of mat. The 
human breast mimic was set to an angle of 30¡ downwards from the vertical axis. Fractions 
were collected for a period of 40 s each with a total of 30 fractions, amounting to a total of 20 
min. This duration corresponds to double the time of an average breastfeed (Geddes et al., 
2008), and was chosen based on previously published breastfeeding simulation by Scheuerle et 
al. to allow for comparative analysis (Scheuerle et al., 2017). All samples collected by the 
fraction collector were weighted using a Sartorius analytic balance (Epsom, UK), and 
subsequently stored at -80¡C until further analysis.  
 
 
 
Figure 3: Example pressure profiles during zinc delivery experiments using the breastfeeding 
simulation apparatus, depicted for 10 s at t = 120-130 s. Dosage forms used for the TNS were 
zinc-loaded fibre mats a) type A, and b) type B. Experiments were conducted using an average 
flow rate of approximately 5.0 mL min-1. 
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Both the overall amount of zinc loaded onto the fibre mats used for experimental procedures, 
as well as the zinc content in collected fractions during breastfeeding simulation, were evaluated 
using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES) at the MRC 
Human Nutrition Research Unit (Cambridge, UK). Zinc detection in nine out of the 30 human 
milk samples was performed according to a protocol by Scheuerle et al., while the zinc 
concentration within the unmeasured human milk samples was subsequently evaluated by 
means of linear interpolation (Scheuerle et al., 2017). The amount of elemental zinc loaded onto 
the non-woven fibre mats was evaluated as follows: Fibre mats were added to a vial containing 
1 mL rinse of ultra-high purity water with 0.002% TritonX100. Following two 10-minute 
rounds of ultra-sonication, all vials were placed on a shaker plate for gentle shaking at night, 
and 1 mL of rinse was added during the day. This process was performed for a total of three 
nights/days, following which the samples were held in a 40¡C water bath over night. After a 
1:10 volumetric dilution in ultra-purity water, samples were diluted 1:20 volumetrically in a 
diluent, consisting of ultra-high purity water (Sartorius Stedium Biotech Arium pro UV Water 
polisher) with 0.002 % TritonX100 (Sigma-Aldrich, UK) and a standard of 1 ppm molybdenum 
(SPEX CertiPrep Metuchen, NJ). All sample solutions were vortexed using a Fisherbrand 
Whirlimixer (Loughborough, UK), and subsequently analysed according to the ICP-OES 
protocol as described by Scheuerle et al. (Scheuerle et al., 2017). Data obtained was used to 
generate a release profile and to evaluate the cumulative zinc release.  
 
3. Results and discussion  
3.1. Scanning Electron Microscope analysis 
SEM images of unloaded and zinc sulphate loaded Texel fibre mats type A and type B were 
obtained to explore the fibre mats morphology (see Figure 4 and Figure 5). It was found that 
despite their difference in g m-2 and thickness, both fibre mat types have the same fibrous 
structure and an approximate fibre diameter of 20 µm. Zinc sulphate was identified qualitatively 
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by morphological analysis, indicating its adsorption in localized areas scattered across the 
fibrous mat network, either in form of flat patches or clumps. It forms a cracked, but mostly 
uniform coating on the fibre surface, caused by the evaporation of water from the loaded zinc 
sulphate solution. Due to the porous structure, adsorption within the deeper regions of the fibre 
mats can be observed. 
Figure 4: SEM results for fibre mat type A. SEM images illustrating the surface of Texel fibre 
mat type A (1.8 mm targeted thickness, 225 g m-2) at different magnifications. Images a) - c) 
present unloaded fibre mats, images, d) - f) fibre mats loaded with zinc sulphate.  
Figure 5: SEM results for fibre mat type B. Illustration of results obtained for SEM analysis of 
Texel fibre mat type B (2.1 mm targeted thickness, 325 g m-2) at different magnifications. 
Images a) - c) present unloaded fibre mats, images d) - f) fibre mats loaded with zinc sulphate. 
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3.2. X-ray Micro Computed Tomography 
X-ray Micro Computed Tomography (XµCT) was used to investigate the ILEUHPDWV¶SRURVLW\
and 3D structure. Figure 6 and Figure 7 illustrate loaded and unloaded Texel fibre mats type A 
and type B, respectively. Different colours refer to material of different density, red indicating 
low and green high density material. Based on the density values of viscose (1.52 g cm-3) (Koc 
and Cincik, 2013), polyester (1.38 g cm-3) (Koc and Cincik, 2013), and zinc sulphate (3.54 g 
cm-3) (FisherScientific, 2014), the presented colour scale was chosen to illustrate unloaded fibre 
material of comparably lower density in red, and zinc sulphate of comparably higher density in 
blue and green colour. While Figure 6 and Figure 7 depict varying amounts of fibre material in 
images d) - e), image f) solely displays loaded zinc sulphate. This becomes particularly apparent 
in direct comparison with the unloaded fibre mats in images a) ± c), in which the visible fibrous 
material at medium density can only barely be visible as a faint silhouette, with mostly light 
EOXHVSRWVRIȝPDQGVSRUDGLFDOO\ODUJHUVSRWVRIȝPVL]HYLVLEOH The bottom side of 
fibre mat type A, unlike fibre mat type B exhibits a fibrous structure similar in appearance to 
those of unloaded fibre mats (see Figure 8). In agreement with the SEM analysis we found that 
WKHGLDPHWHURI LQGLYLGXDO ILEUHVZDVDSSUR[LPDWHO\ȝPIRUXQORDGHGRUSDUWLDOO\ ORDGHG
fibres. Loading with zinc sulphate appears to result in swelling of individual fibres as well as 
fusing of adjoined fibres where they physically touch or where they are sufficiently close to 
come in contact during swelling. As a result, individual fibres are no longer identifiable in areas 
of high zinc loading. Figure 9 shows examples of representative cross-sectional cuts through a 
swollen fibre cluster. The volume fraction, porosity, and total surface area were calculated for 
a cubical region of interest measuring 0.998 mm3 from the fibre PDWV¶FHQWUH (Table 1).  
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Figure 6: ,PDJHVJHQHUDWHGIURP;ȝ&7PHDVXUHPHQWVRID - c) unloaded, and d) - f) zinc 
sulphate loaded Texel fibre mat type A (1.8 mm targeted thickness, 225 g m-2). The colour maps 
were the same for all images and only the opacity was adjusted in order to visualize components 
of different densities. Red colour indicates low, green high density material. The images depict 
only half of the fibre mats in order to visualize the cross-section at the centre of each sample. 
 
 
Figure 7: ,PDJHVJHQHUDWHGE\;ȝ&7DQDO\VLVRID- c) unloaded, and d) - f) zinc sulphate 
loaded Texel fibre mat type B (2.1 mm targeted thickness, 325 g m-2). 
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Figure 8: Images generated IRU ;ȝ&7 DQDO\VLV RI ORDGHG
Texel fibre mats a) type A, b) type B (bottom side facing up).  
 
 
 
 
 
 
 
 
 Parameter Unloaded Loaded Change [%] 
Fibre mat type A 
Porosity [-] 0.942 0.607 - 36 
Surface area [mm2] 19.72 32.70 + 66 
Volume [mm3] 0.058 0.392 + 580 
Fibre mat type B 
Porosity [-] 0.939 0.416 - 56 
Surface area [mm2] 17.30 50.90 + 194 
Volume [mm3] 0.061 0.583 + 856 
 
Table 1: Overview of porosity, surface area, and volume of a cubical region of interest 
measuring 0.998 mm3 taken from the loaded and XQORDGHGILEUHPDWV¶FHQWUH 
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Figure 9: Cut through zinc-loaded fibres in the y-z plane. Images a) - c) illustrate the resulting 
cross-sectional images at different position in the x-direction. Zinc-loaded fibres appear swollen 
and fused with adjoined fibres to form high-density fibre clusters. 
 
 
3.3. Release of zinc from non-woven fibres 
The average total elemental zinc content loaded onto the fibre mat amounted to  
6.17 ± 0.27 mg for fibre mat type A, and 6.4 ± 0.05 mg for fibre mat type B. The cumulative 
normalized proportion of zinc released and the normalized proportion of zinc released in 
individual fractions over time are illustrated in Figure 10. The amount of human milk passed 
through the TNS, as well as the absolute recovery achieved for both fibre mat types are 
presented in Table 2. Effectiveness and duration of release for both fibre mat types were 
comparable. 
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Figure 10: Release of zinc sulphate from Texel fibre mats type A (1.8 mm targeted thickness, 
235 g m-2) and type B (2.1 mm targeted thickness, 335 g m-2), as well as from rapidly 
disintegrating tablets by Scheuerle et al. (Scheuerle et al., 2017) into human milk using the 
breastfeeding simulation apparatus by Gerrard et al. (Gerrard et al., 2012). Experiments were 
conducted at 33.7 - 35.7¡C, and a mean flow rate of approximately 5.0 mL min-1 was applied. 
a) Cumulative normalized proportion of zinc sulphate released and b) Normalized proportion 
of zinc sulphate released in each fraction over time. Release is represented as a percentage of 
the total amount loaded onto the non-woven fibre mats to the total amount released. Each set 
of points represents the average of three experiments, using the mean of ICP-OES triplicate 
measurements for each fraction shown. 
 
 Recovery achieved [%] Amount of human milk 
passed through the device [g] 
Mat type A 64.00 ± 0.01 93.09 ± 1.08 
Mat type B 61.64  ± 0.01 98.15 ± 0.97 
 
Table 2: Recovery achieved and human milk passed through the TNS for the delivery of zinc 
from Texel non-woven fibres using the breastfeeding simulation apparatus within the duration 
of 20 minutes (fractions of 40 s each with a total of 30 fractions). 
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Full delivery of zinc into human milk within the duration of one breastfeed, as previously 
demonstrated to amount to 76.0 ± 12.6 g of human milk for 1-month- to 6-months-old infants 
(Kent et al., 2006), has not been achieved. This could potentially be caused by milk components 
accumulating within the porous mat structure, thereby hampering the flow of milk through, and 
thus the delivery of zinc from the fibre network. The nature and absorption properties of the 
API significantly affect the release rate, however recent research appears to suggest that the 
lipid content and distribution within the milk influences the absolute recovery: Previous studies 
of SDS delivery from Texel non-woven fibres within a Sinnex filter holder LQWRFRZ¶Vmilk 
have shown that absolute release was decreased to 30 - 60 % when using non-homogenized 
milk (5.2 % fat) as opposed to 70 - 90% for use of an homogenized form (3.6 % fat)  (Gerrard 
et al., 2012). SDS release of approximately 100 % into non-hRPRJHQL]HG JRDW¶V PLON 
(4.0 % fat) however, made Gerrard et al. conclude that in addition to the concentration and 
distribution of lipids, the overall milk composition, including carbohydrates, proteins, and 
lipids, has an impact on the API release rate from Texel non-woven fibres (Gerrard et al., 2012). 
Both observations present a challenge for the development of a standardized protocol for 
therapeutic release via non-woven Texel fibre mats, as human milk is a complex fluid with 
highly variable properties. To give but one example, absolute fat content of human milk can 
vary up to three fold, depending on the stage of lactation, dietary requirements and health status 
of the breastfeeding mother (Vir, 2011). Potential surface modifications, such as plasma 
treatment, use of the wet chemical method, or graft polymerization of the fibreV¶ surface (Ikada, 
1994; Yoo et al., 2009), could provide a means to address unwanted milk components 
accumulation while enhancing adsorption properties, yet thereby also increasing manufacturing 
effort and cost of production. 0RUHRYHUWKHREWDLQHG;ȝ&7UHVXOWVDOVRVXJJHVWWKDWFKDQJHV
in fibre conformation are likely impacting the release properties of the Texel fibre mats. Given 
the decrease in porosity as a result of the zinc loading process, flow of human milk through the 
fibrous structure is restricted following loading, and can further be impacted by the 
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accumulation of milk components. Previously, it was reported that the release from low surface 
area to volume hydroxypropylmethylcellulose tablets is slower (Reynolds et al., 2002), and 
similarly, based on literature by Siepmann et al. (Siepmann and Siepmann, 2012), the release 
from zinc-loaded fibre clusters with their reduced surface to volume ratio is believed to be 
VORZHGGRZQ7KH;ȝ&7GDWDRIXQORDGHGfibre mats revealed the presence of fibres of higher 
density than originally expected based on the densities of viscose and polyester. In addition, 
fibre accumulation and/or the presence of impurities can be observed as indicated by the  
10 ± ȝPVL]HGVSRWVWKDWDUHYLVLEOHDWPHGLXPGHQVLW\YDOXHVLQWKH;ȝ&7GDWDEHOLHYHG
WREHDUHVXOWRIWKHILEUHV¶PDQXIDFWXULQJSURFHVVDQGRUFDXVHGE\WUDSSHGGXVWSDUWLFOHVThe 
even distribution of zinc within the fibre mat network of fibre mat type B in contrast to mat 
type A (Figure 8) is attributed to the larger fibre diameter and different wetting behaviour of 
the two fibre mats. The liquid absorption of the fibre mats as well as of the individual fibres is 
driven by capillary action and strongly influenced by the porosity of the samples (Chen et al., 
1995). It would also explain the unequal changes in porosity, surface area, and volume of fibre 
mat type A and B following loading, which however do not lead to an observed difference in 
release from both mats.  
Overall, the absolute release of zinc from Texel non-woven fibres is 20 - 48% superior 
compared to rapidly disintegrating tablets manufactured by direct compression: In a study by 
Scheuerle et al. achieved absolute recovery amounted to only 32 - 51% (Scheuerle et al., 2017). 
It has to be noted that the total elemental zinc content of the rapidly disintegrating tablets  
(17.81 -18.21 mg)  was higher than the amount of elemental zinc loaded onto the Texel non-
woven fibre mats used in this study (6.17-6.40 mg) (Scheuerle et al., 2017). Yet, while the main 
release from non-woven fibres occurred within the first 8 min, the release profile using rapidly 
disintegrating tables was linear, meaning that after 8 min the estimated elemental zinc content 
ranged between 2 - 4 mg (Scheuerle et al., 2017). This was significantly lower than the release 
from Texel non-woven fibre mats at 8 min. In addition to their superior release properties, the 
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tested Texel non-woven fibre mats are characterized by enhanced loading feasibility and cost-
effectiveness compared to the referenced rapidly disintegrating tablets, supporting their use as 
a dosage form of the TNS.  
Important factors to be taken into consideration prior to in-vivo studies are fibre cohesion in 
order to exclude the possibility of fibre break-off, palatability, biocompatibility, and long-time 
stability. Moreover, use of different fibre materials, and different fibre types, such as fast-
disintegrating electrospun fibres fabricated into non-woven film, could be investigated in future 
research. 
 
4. Conclusions  
Using a breastfeeding simulation apparatus to mimic the process of lactation and infant feeding, 
delivery of zinc sulphate from non-woven Texel fibre mats into human milk was investigated. 
With an absolute elemental zinc recovery of 64% (fibre mat type A) and 62% (fibre mat  
type B) respectively in 93 g and 98 g of human milk passed through the fibre insert, full delivery 
within one breastfeed (approximately 76 g) has not been achieved. This can be attributed to the 
complex properties of human milk and accumulation of milk components within the porous mat 
structures, as well as structural changes of the fibre networks following loading, thereby 
hampering the delivery of zinc. In comparison to previous experiments however, the absolute 
zinc recovery using non-woven Texel fibre mats was identified as superior to the release by 
means of rapidly disintegrating tablets (Scheuerle et al., 2017). Based on the non-woven fibre 
PDWV¶release characteristics and cost-effectiveness, non-woven fibres can be regarded as an 
advantageous dosage form for oral drug delivery using the TNS. Further research will be 
required to establish Texel non-woven fibres as a generalized matrix for oral drug delivery, and 
to further explore alternative fibrous materials with advantageous characteristics for API 
delivery into human milk. 
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